Target Price | $29.17 |
Price | $9.49 |
Potential |
207.34%
register free of charge
|
Number of Estimates | 6 |
6 Analysts have issued a price target KalVista Pharmaceuticals, Inc. 2025 .
The average KalVista Pharmaceuticals, Inc. target price is $29.17.
This is
207.34%
register free of charge
$39.00
310.96%
register free of charge
$18.00
89.67%
register free of charge
|
|
A rating was issued by 7 analysts: 7 Analysts recommend KalVista Pharmaceuticals, Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the KalVista Pharmaceuticals, Inc. stock has an average upside potential 2025 of
207.34%
register free of charge
|
Apr '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -3.44 | -3.99 |
3.30% | 15.99% | |
P/E | negative | |
EV/Sales | 14.59 |
1 Analysts have issued a KalVista Pharmaceuticals, Inc. forecast for earnings per share. The average KalVista Pharmaceuticals, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
KalVista Pharmaceuticals, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.